Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-83.42	71.97	434.14
Graham Fair Price	21.79	2.10	1.73
PEG	149.07	-0.07	0.03
Price/Book	-28.53	0.60	0.85
Price/Cash Flow	52.79	59.45	38.91
Prices/Earnings	-50.96	17.94	-36.58
Price/Sales	-33.54	12.07	18.16
Price/FCF	52.79	59.45	38.91
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	94.45	0.65	0.34
Operating Margin	-30.44	0.15	-0.22
ROA	47.59	< 0.005	< 0.005
ROE	< 0.005	< 0.005	45.73
ROIC	< 0.005	< 0.005	-24.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	< 0.005	627.27
Dividends QOQ	-0.43	0.68	57.25
EBIT QOQ	-181.49	1.76	-99.03
EPS QOQ	-12.54	2.47	-80.31
FCF QOQ	13.67	-0.53	-96.14
Revenue QOQ	< 0.005	0.09	830.99
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1111.17	1963.31	76.69
Days Sales Outstanding (DSO)	120.59	86.88	-27.96
Inventory Turnover	0.08	0.05	-43.40
Debt/Capitalization	0.40	0.45	13.72
Quick Ratio	0.16	0.13	-17.10
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.79	4.83	0.88
Cash	0.26	0.22	-15.41
Capex	-0.01	-0.02	-27.35
Free Cash Flow	0.10	0.05	-52.81
Revenue	0.22	0.24	8.48
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.69	0.70	1.33
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	212.73	40.74	-80.85
Naive Interpretation	Member

06 - Financial Health · Bad

Rating